critical role for mast cell Stat5 activity in skin inflammation

Cell Reports

Volumn 6, Issue 2, 2014, Pages 366-376

  Ando, Tomoaki ^a   Xiao, Wenbin ^a   Gao, Peisong ^b   Namiranian, Siavash ^c   Matsumoto, Kenji ^d   Tomimori, Yoshiaki ^a,k   Hong, Hong ^a,j   Yamashita, Hirotaka ^a   Kimura, Miho ^a,l   Kashiwakura, Jun ichi ^e   Hata, Tissa R ^f   Izuhara, Kenji ^g   Gurish, Michael F ^h   Roers, Axel ⁱ   Rafaels, Nicholas M ^b   Barnes, Kathleen C ^b   Jamora, Colin ^c   Kawakami, Yuko ^a   Kawakami, Toshiaki ^a,e  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e RIKEN Center for Integrative Medical Sciences   (Japan)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAGA UNIVERSITY   (Japan)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k DAIICHI SANKYO CO   (Japan)

^l KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE C BETA3; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT5 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMATITIS; FEMALE; GENETIC CODE; HUMAN; KERATINOCYTE; MAJOR CLINICAL STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHP1 GENE; STAT5A GENE; STAT5B GENE; WILD TYPE;

MUS;

ANIMALS; DERMATITIS, ATOPIC; GENE DELETION; HUMANS; MAST CELLS; MICE; MICE, INBRED C57BL; PHOSPHOLIPASE C BETA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; SKIN; STAT5 TRANSCRIPTION FACTOR;

EID: 84895910886     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.12.029     Document Type: Article

References (44)

1. Allakhverdi Z., Comeau M.R., Jessup H.K., Yoon B.R., Brewer A., Chartier S., Paquette N., Ziegler S.F., Sarfati M., Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J.Exp. Med. 2007, 204:253-258.
2. Ando T., Matsumoto K., Namiranian S., Yamashita H., Glatthorn H., Kimura M., Dolan B.R., Lee J.J., Galli S.J., Kawakami Y., et al. Mast cells are required for full expression of allergen/SEB-induced skin inflammation. J.Invest. Dermatol. 2013, 133:2695-2705.
3. Arinobu Y., Iwasaki H., Gurish M.F., Mizuno S., Shigematsu H., Ozawa H., Tenen D.G., Austen K.F., Akashi K. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc. Natl. Acad. Sci. USA 2005, 102:18105-18110.
4. Beck L.A., Boguniewicz M., Hata T., Schneider L.C., Hanifin J., Gallo R., Paller A.S., Lieff S., Reese J., Zaccaro D., et al. Phenotype of atopicdermatitis subjects with a history of eczema herpeticum. J.Allergy Clin. Immunol. 2009, 124:260-269. e1-e7.
5. Bieber T. Atopic dermatitis. N.Engl. J. Med. 2008, 358:1483-1494.
6. Bogiatzi S.I., Fernandez I., Bichet J.C., Marloie-Provost M.A., Volpe E., Sastre X., Soumelis V. Cutting Edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J.Immunol. 2007, 178:3373-3377.
7. Boguniewicz M., Leung D.Y. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol. Rev. 2011, 242:233-246.
8. Bratton D.L., Hamid Q., Boguniewicz M., Doherty D.E., Kailey J.M., Leung D.Y. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J.Clin. Invest. 1995, 95:211-218.
9. Burd P.R., Thompson W.C., Max E.E., Mills F.C. Activated mast cells produce interleukin 13. J.Exp. Med. 1995, 181:1373-1380.
10. Chen C.C., Grimbaldeston M.A., Tsai M., Weissman I.L., Galli S.J. Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. USA 2005, 102:11408-11413.
11. Dahl C., Hoffmann H.J., Saito H., Schiøtz P.O. Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured invitro. Allergy 2004, 59:1087-1096.
12. Eichenfield L.F., Hanifin J.M., Luger T.A., Stevens S.R., Pride H.B. Consensus conference on pediatric atopic dermatitis. J.Am. Acad. Dermatol. 2003, 49:1088-1095.
13. Gebhardt T., Sellge G., Lorentz A., Raab R., Manns M.P., Bischoff S.C. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. Eur. J. Immunol. 2002, 32:2308-2316.
14. Gouilleux F., Wakao H., Mundt M., Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 1994, 13:4361-4369.
15. Hamilton D.W. Functional role of periostin in development and wound repair: implications for connective tissue disease. J.Cell Commun. Signal. 2008, 2:9-17.
16. Hanifin J.M., Thurston M., Omoto M., Cherill R., Tofte S.J., Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp. Dermatol. 2001, 10:11-18. EASI Evaluator Group.
17. Isaksen D.E., Baumann H., Trobridge P.A., Farr A.G., Levin S.D., Ziegler S.F. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J.Immunol. 1999, 163:5971-5977.
18. Jin H., He R., Oyoshi M., Geha R.S. Animal models of atopic dermatitis. J.Invest. Dermatol. 2009, 129:31-40.
19. Jin H., Oyoshi M.K., Le Y., Bianchi T., Koduru S., Mathias C.B., Kumar L., Le Bras S., Young D., Collins M., et al. IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J.Clin. Invest. 2009, 119:47-60.
20. Kawakami Y., Yumoto K., Kawakami T. An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases. Allergol. Int. 2007, 56:403-409.
21. Kawakami T., Ando T., Kimura M., Wilson B.S., Kawakami Y. Mast cells in atopic dermatitis. Curr. Opin. Immunol. 2009, 21:666-678.
22. Kusakabe K., Xin K.Q., Katoh H., Sumino K., Hagiwara E., Kawamoto S., Okuda K., Miyagi Y., Aoki I., Nishioka K., et al. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J.Immunol. 2000, 164:3102-3111.
23. Li M., Messaddeq N., Teletin M., Pasquali J.L., Metzger D., Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc. Natl. Acad. Sci. USA 2005, 102:14795-14800.
24. Liu Y.J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J.Exp. Med. 2006, 203:269-273.
25. Masuoka M., Shiraishi H., Ohta S., Suzuki S., Arima K., Aoki S., Toda S., Inagaki N., Kurihara Y., Hayashida S., et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J.Clin. Invest. 2012, 122:2590-2600.
26. Mui A.L., Wakao H., O'Farrell A.M., Harada N., Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 1995, 14:1166-1175.
27. Pardanani A., Gotlib J.R., Jamieson C., Cortes J.E., Talpaz M., Stone R.M., Silverman M.H., Gilliland D.G., Shorr J., Tefferi A. Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis. J.Clin. Oncol. 2011, 29:789-796.
28. Rodewald H.R., Feyerabend T.B. Widespread immunological functions of mast cells: fact or fiction?. Immunity 2012, 37:13-24.
29. Ruan K., Bao S., Ouyang G. The multifaceted role of periostin intumorigenesis. Cell. Mol. Life Sci. 2009, 66:2219-2230.
30. Saito H., Hatake K., Dvorak A.M., Leiferman K.M., Donnenberg A.D., Arai N., Ishizaka K., Ishizaka T. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc. Natl. Acad. Sci. USA 1988, 85:2288-2292.
31. Scholten J., Hartmann K., Gerbaulet A., Krieg T., Müller W., Testa G., Roers A. Mast cell-specific Cre/loxP-mediated recombination invivo. Transgenic Res. 2008, 17:307-315.
32. Shin K., Gurish M.F., Friend D.S., Pemberton A.D., Thornton E.M., Miller H.R., Lee D.M. Lymphocyte-independent connective tissue mast cells populate murine synovium. Arthritis Rheum. 2006, 54:2863-2871.
33. Sonkoly E., Muller A., Lauerma A.I., Pivarcsi A., Soto H., Kemeny L., Alenius H., Dieu-Nosjean M.C., Meller S., Rieker J., et al. IL-31: a new link between Tcells and pruritus in atopic skin inflammation. J.Allergy Clin. Immunol. 2006, 117:411-417.
34. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 2002, 3:673-680.
35. Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J.Clin. Invest. 1998, 101:1614-1622.
36. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., Fukami K., Kataoka T., Yun S., Ryu S.H. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 2008, 41:415-434.
37. Wollenberg A., Wetzel S., Burgdorf W.H., Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J.Allergy Clin. Immunol. 2003, 112:667-674.
38. Xiao W., Hong H., Kawakami Y., Kato Y., Wu D., Yasudo H., Kimura A., Kubagawa H., Bertoli L.F., Davis R.S., et al. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell 2009, 16:161-171.
39. Xiao W., Ando T., Wang H.Y., Kawakami Y., Kawakami T. Lyn-and PLC-beta3-dependent regulation of SHP-1 phosphorylation controlsStat5 activity and myelomonocytic leukemia-like disease. Blood 2010, 116:6003-6013.
40. Yamamoto N., Sugiura H., Tanaka K., Uehara M. Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels. J.Dermatol. Sci. 2003, 33:121-126.
41. Yasudo H., Ando T., Xiao W., Kawakami Y., Kawakami T. Short Stat5-interacting peptide derived from phospholipase C-β3 inhibits hematopoietic cell proliferation and myeloid differentiation. PLoS ONE 2011, 6:e24995.
42. Yoo J., Omori M., Gyarmati D., Zhou B., Aye T., Brewer A., Comeau M.R., Campbell D.J., Ziegler S.F. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J.Exp. Med. 2005, 202:541-549.
43. Ziegler S.F. Thymic stromal lymphopoietin and allergic disease. J.Allergy Clin. Immunol. 2012, 130:845-852.
44. Ziegler S.F., Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 2010, 11:289-293.